Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
about
Cilostazol for prevention of thrombosis and restenosis after intracoronary stentingPotential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature.Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trialsAllergic reactions to clopidogrel and cross-reactivity to other agents.
P2860
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@ast
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@en
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@nl
type
label
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@ast
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@en
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@nl
prefLabel
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@ast
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@en
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@nl
P2093
P1476
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
@en
P2093
P304
P356
10.1016/S0002-9149(99)00579-2
P407
P577
1999-12-01T00:00:00Z